Previous close | 46.00 |
Open | 45.86 |
Bid | 46.59 x 100 |
Ask | 46.86 x 100 |
Day's range | 45.82 - 46.85 |
52-week range | 32.69 - 52.69 |
Volume | |
Avg. volume | 107,498 |
Market cap | 932.296M |
Beta (5Y monthly) | 0.71 |
PE ratio (TTM) | 89.71 |
EPS (TTM) | 0.52 |
Earnings date | 04 July 2024 - 08 July 2024 |
Forward dividend & yield | 0.24 (0.52%) |
Ex-dividend date | 26 Apr 2024 |
1y target est | 53.67 |
For the seventh consecutive year, the FDA has renewed Simulations Plus' (SLP) license to the DILIsym software system for facilitating drug safety evaluations.
Simulations Plus, Inc. ( NASDAQ:SLP ) investors will be delighted, with the company turning in some strong numbers with...
Simulations Plus ( NASDAQ:SLP ) Second Quarter 2024 Results Key Financial Results Revenue: US$18.3m (up 16% from 2Q...